PREDICTING THE POTENTIAL FOR CANNABIDIOL INDUCED DRUG-DRUG INTERACTIONS WITH MAJOR CYP450 ENZYMES USING MODEL-BASED APPROACHES

被引：0
|
作者：
Eltanameli, B. [1 ]
Al Sahlawi, S. [1 ]
Cicali, B. [1 ]
Cristofoletti, R. [1 ]
机构：
[1] Univ Florida, Coll Pharm, Orlando, FL USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
LB-032
引用
收藏
页码：S37 / S38
页数：2
相关论文
共 50 条
  • [1] Drug-drug interactions: it is not only CYP450's which matter
    David J Back
    Retrovirology, 7
  • [2] Evaluation of the Clinical Drug-Drug Interaction Potential of Pritelivir on Transporters and CYP450 Enzymes Using a Cocktail Approach
    de Vries, Michiel
    Bonsmann, Susanne
    Pausch, Joerg
    Sumner, Melanie
    Birkmann, Alexander
    Zimmermann, Holger
    Kropeit, Dirk
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (07): : 755 - 769
  • [3] Drug-drug interactions: it is not only CYP450's which matter
    Back, David J.
    RETROVIROLOGY, 2010, 7 : 4 - 4
  • [4] CYP450 drug inducibility in NAFLD via an in vitro hepatic model: Understanding drug-drug interactions in the fatty liver
    Rey-Bedon, Camilo
    Banik, Peony
    Gokaltun, Aslihan
    Hofheinz, O.
    Yarmush, Martin. L.
    Uygun, M. Korkut
    Usta, O. Berk
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 146
  • [5] Re: Pergolizzi et al. 2011: Exposure to potential CYP450 pharmacokinetic drug-drug interactions
    Nieminen, Tuija H.
    Hagelberg, Nora M.
    Saari, Teijo I.
    Gronlund, Juha
    Neuvonen, Pertti J.
    Olkkola, Klaus T.
    PAIN PRACTICE, 2012, 12 (01) : 81 - 82
  • [6] Prediction of drug-drug interactions using physiologically-based pharmacokinetic models of CYP450 modulators included in Simcyp software
    Marsousi, Niloufar
    Desmeules, Jules A.
    Rudaz, Serge
    Daali, Youssef
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2018, 39 (01) : 3 - 17
  • [7] Determination of Vatiquinone Drug-Drug Interactions, as CYP450 Perpetrator and Victim, Using Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation
    Lee, Lucy
    Okudaira, Noriko
    Murase, Katsuyuki
    Kong, Ronald
    Jones, Hannah M.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2025, 65 (02): : 160 - 169
  • [8] Exposure to Potential CYP450 Pharmacokinetic Drug-Drug Interactions among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions
    Pergolizzi, Joseph V., Jr.
    Labhsetwar, Sumedha A.
    Puenpatom, R. Amy
    Joo, Seongjung
    Ben-Joseph, Rami
    Summers, Kent H.
    PAIN PRACTICE, 2011, 11 (04) : 325 - 336
  • [9] In Vitro Drug-Drug Interaction Evaluation of GalNAc Conjugated siRNAs Against CYP450 Enzymes and Transporters
    Ramsden, Diane
    Wu, Jing-Tao
    Zerler, Brad
    Iqbal, Sajida
    Jiang, Jim
    Clausen, Valerie
    Aluri, Krishna
    Gu, Yongli
    Dennin, Sean
    Kim, Joohwan
    Chong, Saeho
    DRUG METABOLISM AND DISPOSITION, 2019, 47 (10) : 1183 - 1194
  • [10] Optimizing classification of drug-drug interaction potential for CYP450 isoenzyme inhibition assays in early drug discovery
    Krippendorff, Ben-Fillippo
    Lienau, Philip
    Reichel, Andreas
    Huisinga, Wilhelm
    JOURNAL OF BIOMOLECULAR SCREENING, 2007, 12 (01) : 92 - 99
12345